3-hydroxyflavone has been researched along with Hyperlipidemias in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abukhalil, MH; Al Hroob, AM; Althunibat, OY; Bin-Jumah, M; Germoush, MO; Mahmoud, AM | 1 |
1 other study(ies) available for 3-hydroxyflavone and Hyperlipidemias
| Article | Year |
|---|---|
Fisetin ameliorates oxidative stress, inflammation and apoptosis in diabetic cardiomyopathy.
Topics: Animals; Antioxidants; Apoptosis; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Disease Models, Animal; Flavonoids; Flavonols; Glycated Hemoglobin; Heart Function Tests; Hyperglycemia; Hyperlipidemias; Inflammation; Male; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Wistar; Streptozocin | 2019 |